omega-n-methylarginine has been researched along with Heart Disease, Ischemic in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, RO | 1 |
| Beresewicz, A; Maczewski, M | 1 |
| Boger, RH; Flyvbjerg, A; Frystyk, J; Ledet, T; Moller, N; Orskov, H | 1 |
| Bröijersén, A; Erbas, D; Gonon, AT; Pernow, J; Valen, G | 1 |
| Chilian, WM; Jones, D; Merkus, D; Nishikawa, Y; Stepp, DW | 1 |
| Baker, JE; Chang, CC; Hutchins, W; Jacob, HJ; Khampang, P; Lazar, J; Ogawa, H; Pritchard, KA; Rafiee, P; Shi, Y; Zhang, C | 1 |
| Hachiro, T; Kawahara, K; Nakajima, T; Nakayama, Y; Yamauchi, Y; Yokokawa, T | 1 |
| Hansen, PR; Haunsø, S | 1 |
| Amrani, M; Chester, AH; Jayakumar, J; Schyns, CJ; Yacoub, MH | 1 |
| Schulz, R; Wambolt, R | 1 |
| De Clerck, F; Lu, HR; Remeysen, P | 1 |
| Borland, JA; Chester, AH; Collins, P; Jiang, C; Yacoub, MH | 1 |
| Allen, JW; Davis, PJ; del Nido, PJ; Downing, SE; McGowan, FX; Sobek, M | 1 |
| Ilebekk, A; Kirkebøen, KA; Naess, PA; Offstad, J | 1 |
| Vogel, RA | 1 |
| Agozzino, S; Bernareggi, M; Berti, F; Cereda, R; Giuliani, P; Mizrahi, J; Rossoni, G; Villa, L | 1 |
| Berti, F; Bonazzi, A; Buccellati, C; Folco, G; Maclouf, J; Rossoni, G; Sala, A | 1 |
| Bani, D; Bello, MG; Bigazzi, M; Mannaioni, PF; Masini, E; Sacchi, TB | 1 |
| Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
| Dankelman, J; Goto, M; Kajiya, F; Merkus, D; Spaan, JA; Vergroesen, I; Vink, H | 1 |
| Baydoun, AR; Edwards, RJ; Mann, GE; Marber, MS; Mockridge, JW; Rakhit, RD; Wyatt, AW | 1 |
| Gonon, AT; Gourine, AV; Pernow, J | 1 |
| Hirooka, Y; Ichiki, T; Mohri, M; Takeshita, A | 1 |
1 review(s) available for omega-n-methylarginine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.
Topics: Adult; Animals; Chest Pain; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Female; Humans; Microcirculation; Microvascular Angina; Middle Aged; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Ventricular Function, Left | 2009 |
22 other study(ies) available for omega-n-methylarginine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
Topics: Animals; Coronary Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radicals; Guanidines; Heart; Heart Rate; Hydroxyl Radical; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Perfusion; Rats; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sulfones; Thiourea; Ventricular Function, Left | 2003 |
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
Topics: Causality; Comorbidity; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Humans; Incidence; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine; Risk; Vasodilation | 2003 |
Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Topics: Adenosine Diphosphate; Animals; Bosentan; Cardiotonic Agents; Coronary Circulation; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasodilator Agents | 2004 |
In vivo role of heme oxygenase in ischemic coronary vasodilation.
Topics: Animals; Carbon Monoxide; Coronary Circulation; Cyclic GMP; Cyclooxygenase Inhibitors; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Indomethacin; Microcirculation; Myocardial Ischemia; Myocardium; omega-N-Methylarginine; Potassium Channels; Potassium Chloride; Vasodilation | 2004 |
Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
Topics: Animals; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Myocardial Ischemia; Nerve Tissue Proteins; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; omega-N-Methylarginine; Rats; Rats, Inbred BN; Rats, Inbred Dahl; RNA, Messenger; Species Specificity; Superoxides | 2005 |
Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia.
Topics: Adenosine Triphosphate; Animals; Benzoates; Cell Death; Cells, Cultured; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Imidazoles; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Ornithine; Penicillamine; Rats; Rats, Wistar | 2006 |
Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperaemic response.
Topics: Acetylcholine; Amino Acid Oxidoreductases; Animals; Arginine; Capillary Permeability; Coronary Circulation; Dogs; Heart; Hyperemia; Myocardial Ischemia; NADPH Dehydrogenase; Nitric Oxide Synthase; omega-N-Methylarginine; Technetium Tc 99m Pentetate | 1995 |
L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function.
Topics: Animals; Arginine; Coronary Circulation; Heart; Heart Arrest, Induced; Male; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; omega-N-Methylarginine; Perfusion; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 1995 |
Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.
Topics: Animals; Arginine; Glycogen; Heart; Lactates; Lactic Acid; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Perfusion; Rabbits | 1995 |
Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway?
Topics: Animals; Arginine; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Electrocardiography; Male; Myocardial Ischemia; Myocardial Reperfusion; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arginine; Child; Child, Preschool; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Indomethacin; Infant; Male; Middle Aged; Myocardial Ischemia; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Sex Factors; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1995 |
Endothelium-dependent regulation of coronary tone in the neonatal pig.
Topics: Acetylcholine; Animals; Animals, Newborn; Arginine; Coronary Vessels; Endothelium, Vascular; Indomethacin; Muscle Tonus; Muscle, Smooth, Vascular; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; omega-N-Methylarginine; Perfusion; Swine; Vascular Resistance; Vasodilation | 1994 |
Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts.
Topics: Adenosine; Adenosine Diphosphate; Animals; Arginine; Coronary Circulation; Female; Hemodynamics; Hyperemia; Male; Myocardial Ischemia; Myocardium; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Oxygen Consumption; Swine; Time Factors | 1994 |
Endothelium-dependent vasoregulation of coronary artery diameter and blood flow.
Topics: Acetylcholine; Animals; Arginine; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Humans; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1993 |
Protective effects of ITF 296 in the isolated rabbit heart subjected to global ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzoxazines; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide Synthase; omega-N-Methylarginine; Oxazines; Rabbits; Vasodilator Agents | 1995 |
Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart.
Topics: Animals; Calcimycin; Enzyme Inhibitors; Heart; Hemodynamics; Humans; In Vitro Techniques; Leukotrienes; Male; Myocardial Ischemia; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Rabbits | 1997 |
Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide.
Topics: Animals; Calcium; Coronary Circulation; Cytoplasmic Granules; Enzyme Inhibitors; Guinea Pigs; Heart; Histamine Release; In Vitro Techniques; Male; Malondialdehyde; Mast Cells; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; omega-N-Methylarginine; Relaxin | 1997 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Prolonged diastolic time fraction protects myocardial perfusion when coronary blood flow is reduced.
Topics: Adenosine; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cardiovascular Agents; Coronary Circulation; Diastole; Dogs; Enzyme Inhibitors; Heart; Muscle Relaxation; Myocardial Ischemia; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Time Factors; Vascular Resistance | 1999 |
Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes.
Topics: Alkaloids; Animals; Animals, Newborn; Anti-Infective Agents; Benzophenanthridines; Cells, Cultured; Cyclic GMP; Dexamethasone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Glucocorticoids; Glyburide; Heart Ventricles; Hypoglycemic Agents; Ischemic Preconditioning; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxadiazoles; Penicillamine; Phenanthridines; Potassium Channels; Protein Kinase C; Quinoxalines; Rats; Rats, Sprague-Dawley | 2000 |
Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
Topics: Animals; Endothelin Receptor Antagonists; Endothelins; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; omega-N-Methylarginine; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Swine | 2000 |
Endogenous nitric oxide prevents myocardial ischemia in patients with hypertension and left ventricular hypertrophy.
Topics: Aged; Cardiac Catheterization; Coronary Circulation; Enzyme Inhibitors; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine | 2002 |